Accès ouvert
2025
article
OpenAlex
Renato D. Lópes, Edimar Alcides Bocchi, Luis Eduardo Echeverría, Caroline Demacq et autres
Importance: The efficacy and safety of guideline-recommended treatments for heart failure (HF) are uncertain in patients with Chagas disease. Objective: To evaluate the efficacy and safety of the angiotensin receptor-neprilysin inhibitor sacubitril/valsartan in patients with HF with reduced ejection fraction due to …
us, br, co, in, ca, ar, mx, es, ch, gb
(code pays fourni par la source)
Accès ouvert
2022
article
OpenAlex
Sylvia K. Haas, A. John Camm, Harald Darius, Jan Steffel et autres
de, gb, ch, at
(code pays fourni par la source)
Accès ouvert
2019
article
OpenAlex
Shinya Goto, Pantep Angchaisuksiri, Jean‐Pierre Bassand, A. John Camm et autres
Background Using data from the GARFIELD ‐ AF (Global Anticoagulant Registry in the FIELD –Atrial Fibrillation), we evaluated the impact of chronic kidney disease ( CKD ) stage on clinical outcomes in patients with newly diagnosed atrial fibrillation ( AF ). Methods …
jp, th, fr, gb, dk, au, us, cn, de, sg, kr, in, ca, nl
(code pays fourni par la source)
Accès ouvert
2018
article
OpenAlex
Jitendra PS. Sawhney, Veerappa Annasaheb Kothiwale, Vikas Bisne, Rajashekhar Durgaprasad et autres
BACKGROUND: The Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF) is an ongoing prospective noninterventional registry, which is providing important information on the baseline characteristics, treatment patterns, and 1-year outcomes in patients with newly diagnosed non-valvular atrial fibrillation (NVAF). This report describes …
in, pk, gb, us
(code pays fourni par la source)